Today is the day dedicated to the more than 300 million people living with rare diseases worldwide.
We are proud to play our part in this movement!
More than ever, the FarmaMondo Group is committed to helping rare disease patients gain access to much needed treatments in emerging markets. We operate globally or locally in many therapeutic areas in the field of rare diseases: paediatric haematology, oncology, metabolism, nephrology, neurology and ophthalmology.
FarmaMondo supports biopharmaceutical companies in providing access to specialty medicines for patients in need, through Named Patient Programmes and eventually commercialisation.
To find out more about what we do:
https://farmamondo.com/services/managed-access-programs/ or https://farmamondo.com/services/licensed-medicines/
